SkinMedica and Allergan brand loyalty and rebate program terms have changed since last review, with no public announcement from the manufacturer. This is a critical early-warning flag: manufacturer terms can shift silently, directly impacting per-unit toxin and per-syringe filler economics and your practice's gross margin on injectables.
Compliance
Warning: SkinMedica/Allergan Loyalty Program Terms Shifted — Review Your Rebate Structure Now
Manufacturer rebate and loyalty terms changed without announcement; injector margins at risk.
Manufacturer terms shifted with no announcement; audit your rebate structure immediately.
Manufacturer loyalty programs (Alle, Aspire, Evolus Rewards, etc.) often include volume rebates, tiered pricing, and exclusivity incentives that can swing 5–15% of injectable revenue depending on your purchasing pattern and tier status. Changes to rebate thresholds, minimum volumes, or exclusivity requirements can erode profitability without warning. Action: audit your current SkinMedica/Allergan contract terms against the published program page immediately, reconcile any discrepancies with your account manager, and model the financial impact of any adverse changes before they hit your P&L.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.